Esther Dillard: Access to Gene Therapy for Sickle Cell Disease
Esther Dillard, Anchor and Reporter for the Black Information Network at iHeartMedia, shared a post on LinkedIn:
“Gene therapy for sickle cell disease is one of the safest cures medicine has ever produced. A one-time treatment. Not a lifetime of transfusions and pain crises. A cure.
But access isn’t equal.
In this week’s episode of The Color Between the Lines, Dr. Haydar Frangoul explains why families in places like Alabama often have to travel hundreds of miles and wait months just to reach a center that can perform this treatment. That’s not an accident. That’s a choice, about where hospitals invest, who gets access to specialists, and which communities get left out of medical breakthroughs.
Full conversation this week.”
Stay updated with Hemostasis Today.
-
Oct 11, 2026, 22:40Bahram Alamdary Badlou: Platelets as First Responders in Hemostasis, Immunity, and Inflammation
-
Oct 11, 2026, 22:22Vipin Singh: New Publication on Hippo-YAP Signaling and Platelet Activation
-
Oct 11, 2026, 22:21Trygve Berge: New AFNOR Paper on AF-related Stroke in Norway
-
Oct 11, 2026, 22:09Omar Alomari: Our New Publication on Apixaban vs Rivaroxaban for VTE
-
Oct 11, 2026, 21:22Shayan Roshan: Happy to Share Two Research Milestones in Trauma Care and Pancreatic Cancer
-
Oct 11, 2026, 21:16Chokri Ben Lamine: Anemia in Myelofibrosis – Multiple Mechanisms, Limited Responses
-
Oct 11, 2026, 21:03Carmela Walker: Supporting Warriors Living With SCD Through Dental Care and Advocacy
-
Oct 11, 2026, 21:00Rishdha Roshad: Intraoperative Cell Salvage – Turning Blood Loss into an Opportunity for Recovery
-
Oct 11, 2026, 20:59Anthony R. Sloan: Honored to Share Our Work at the 20th Midwest Platelet Conference